<?xml version="1.0"?>

<document>
	<title>Amikacin therapy of exacerbations of Pseudomonas aeruginosa
   infections in patients with cystic fibrosis.</title>

	<author>Lau-W-K.</author>
	<author>Young-L-S.</author>
	<author>Osher-A-B.</author>
	<author>Dooley-R-R.</author>

	<source>Pediatrics. 1977 Sep. 60(3). P 372-7.</source>

	<abstract>Amikacin, a new semisynthetic aminoglycoside antibiotic with activity
   against Pseudomonas aeruginosa, was used to treat 22 acute
   exacerbations of chronic pulmonary infections in 18 patients with
   cystic fibrosis. Patients ranged from 5 to 32 years of age and had
   mucoid P. aeruginosa isolated from sputum. The amikacin dose was
   usually 7.5 mg/kg every eight hours but was increased to 10 mg/kg
   and/or carbenicillin was added in selected cases depending on
   clinical course. Although P. aeruginosa was not eliminated from our
   patients&apos; sputum except in two cases, there was a good clinical
   response in 19 of 22 courses. Significant improvement in chest x-ray
   films, spirometry, or arterial oxygen tension was documented in 11 of
   17 courses. One instance of serum creatinine level elevation could
   not be attributed to this antibiotic. Two patients showed minimal (15
   dB) unilateral high-frequency hearing loss on serial audiograms.
   Activity against many gentamicin-resistant strains and high blood
   levels are among the attractive properties of amikacin. Amikacin is
   clinically effective in treating Pseudomonas-associated pulmonary
   infections complicating cystic fibrosis.</abstract>

	<majorsubject>AMIKACIN: tu</majorsubject>
	<majorsubject>CYSTIC-FIBROSIS: co</majorsubject>
	<majorsubject>KANAMYCIN: aa</majorsubject>
	<majorsubject>PSEUDOMONAS-INFECTIONS: dt</majorsubject>
	<majorsubject>RESPIRATORY-TRACT-INFECTIONS: dt</majorsubject>

	<minorsubject>ACUTE-DISEASE</minorsubject>
	<minorsubject>ADOLESCENCE</minorsubject>
	<minorsubject>ADULT</minorsubject>
	<minorsubject>AMIKACIN: ad</minorsubject>
	<minorsubject>CHILD</minorsubject>
	<minorsubject>CHILD-PRESCHOOL</minorsubject>
	<minorsubject>FEMALE</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>MALE</minorsubject>
	<minorsubject>PSEUDOMONAS-AERUGINOSA</minorsubject>
	<minorsubject>RESPIRATORY-TRACT-INFECTIONS: et</minorsubject>
	<minorsubject>SUPPORT-U-S-GOVT-P-H-S</minorsubject>

	<reference>001   SHWACHMAN H           AM J DIS CHILD                  96     6 958</reference>
	<reference>002   LAWSON D              IN: WATT PJ                           69 970</reference>
	<reference>003   DOGGETT RG            IN: LAWSON D PROC 5TH INT CF         175 969</reference>
	<reference>004   RUCKER RW             PEDIATRICS                      54   358 974</reference>
	<reference>005   MEARNS MB             ARCH DIS CHILD                  47   902 972</reference>
	<reference>006   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   82   541 974</reference>
	<reference>007   MAY JR                ARCH DIS CHILD                  47   908 972</reference>
	<reference>008   HUANG NN              J PEDIATR                       59   512 961</reference>
	<reference>009   MCCRAE WM             SCOTT MED J                     19   187 974</reference>
	<reference>010   MEARNS MB             ARCH DIS CHILD                  47     5 972</reference>
	<reference>011   ROLINSON GN           IN: LAWSON D PROC 5TH INT CF         214 969</reference>
	<reference>012   HAWLEY HB             CURR THER RES                   16   414 974</reference>
	<reference>013   HOFF GE               SCAND J INFECT DIS               6   333 974</reference>
	<reference>014   BOXERBAUM B           J INFECT DIS SUPPL             124   293 971</reference>
	<reference>015   BOXERBAUM B           J INFECT DIS SUPPL             122    59 970</reference>
	<reference>016   HUANG NN              J PEDIATR                       78   338 971</reference>
	<reference>017   PARRY MF              PROC ICAAC 15TH ABST 335                 975</reference>
	<reference>018   BODEY GP              ANTIMICROB AGENTS CHEMOTHER      4   186 973</reference>
	<reference>019   YOUNG LS              ANTIMICROB AGENTS CHEMOTHER      4   617 973</reference>
	<reference>020   YU PKW                ANTIMICROB AGENTS CHEMOTHER      4   133 973</reference>
	<reference>021   PRICE KE              J ANTIBIOT (TOKYO)              25   709 972</reference>
	<reference>022   MEYER RD              ANN INTERN MED                  83   790 975</reference>
	<reference>023   CLARKE JT             CLIN PHARMACOL THER             15   610 974</reference>
	<reference>024   BODEY GP              ANTIMICROB AGENTS CHEMOTHER      5   508 974</reference>
	<reference>025   STEVENS P             J LAB CLIN MED                  86   349 975</reference>
	<reference>026   STEVENS P             ANTIMICROB AGENTS CHEMOTHER      7   374 975</reference>
	<reference>027   BLACK RE              ANTIMICROB AGENTS CHEMOTHER      9   956 976</reference>

	<citation>1   KRAUSE PJ             CURR THER RES CLIN EXP          25   609 979</citation>
	<citation>2   BEAUDRY PH            J PEDIATR                       97   144 980</citation>
	<citation>3   PIEN FD               AM J HOSP PHARM                 38   981 981</citation>
	<citation>4   MEYER RD              ANN INTERN MED                  95   328 981</citation>
	<citation>5   MARKS MI              J PEDIATR                       98   173 981</citation>
	<citation>6   HYATT AC              J PEDIATR                       99   307 981</citation>
	<citation>7   LEVY J                J ANTIMICROB CHEMOTHER          10   227 982</citation>
	<citation>8   KELLY HB              J PEDIATR                      100   318 982</citation>
	<citation>9   FRASER GL             J PEDIATR                      101   792 982</citation>
	<citation>10   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    75 982</citation>
	<citation>11   GUAY DRP              DRUG INTEL CLIN PHARM           17    83 983</citation>
	<citation>12   SZAFF M               ACTA PAEDIATR SCAND             72   651 983</citation>
	<citation>13   KELLY HW              DRUG INTEL CLIN PHARM           18   772 984</citation>
	<citation>14   FRASER GL             DRUG INTEL CLIN PHARM           19   757 985</citation>
	<citation>15   HOLM SE               REV INFECT DIS                   8  S305 986</citation>
	<citation>16   AUTRET E              EUR J CLIN PHARMACOL            31    79 986</citation>
	<citation>17   PITT TL               J ROY SOC MED                   79    13 986</citation>
	<citation>18   CHADWICK EG           AM J MED                        80   166 986</citation>

</document>
